Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacological treatment of compulsive sexual behaviour disorder
2024-514490-22-01Phase 3Authorised
- Sponsor
- Centrum Medyczne Kształcenia Podyplomowego
- Start
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in hypersexuality comparing Escitalopram arm, Naltrexone arm and Placebo arm (3 arms). Primary endpoints: CSBD-19 score, BPS score and 2 more. Planned start Jun 2025; status: authorised.
02
Drugs
escitalopramnaltrexone
03
Conditions
hypersexuality
Beyond the preview
Go deeper on 2024-514490-22-01.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-514490-22-01.